← FDA DRUG APPROVALS

FDA ANDA · ANDA040640

TRANYLCYPROMINE SULFATE

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA040640
TYPE
ANDA
ORIGINAL APPROVAL
2006-06-29
LATEST ACTION
2024-06-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

TRANYLCYPROMINE SULFATEPrescription
TRANYLCYPROMINE SULFATE EQ 10MG BASE · TABLET · ORAL

Approval history

2024-06-14Labeling · Supplement 13 · standardAP
2010-07-19Labeling · Supplement 9AP
2007-12-12Labeling · Supplement 7AP
2007-12-12Labeling · Supplement 5AP
2006-06-29Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →